SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $222,438 | -31.8% | 1,835 | -35.5% | 0.00% | – |
| Q2 2023 | $326,040 | -21.8% | 2,847 | -5.9% | 0.00% | – |
| Q1 2023 | $416,799 | -3.1% | 3,024 | -8.9% | 0.00% | – |
| Q4 2022 | $430,077 | -32.9% | 3,319 | -42.7% | 0.00% | -100.0% |
| Q3 2022 | $641,000 | +54.1% | 5,789 | +4.4% | 0.00% | – |
| Q2 2022 | $416,000 | -8.0% | 5,545 | -4.1% | 0.00% | – |
| Q1 2022 | $452,000 | +151.1% | 5,784 | +189.1% | 0.00% | – |
| Q4 2021 | $180,000 | +38.5% | 2,001 | +41.6% | 0.00% | – |
| Q3 2021 | $130,000 | +64.6% | 1,413 | +38.8% | 0.00% | – |
| Q2 2021 | $79,000 | +8.2% | 1,018 | +5.3% | 0.00% | – |
| Q1 2021 | $73,000 | -70.6% | 967 | -33.7% | 0.00% | – |
| Q4 2020 | $248,000 | +64.2% | 1,458 | +34.9% | 0.00% | – |
| Q3 2020 | $151,000 | +96.1% | 1,081 | +124.7% | 0.00% | – |
| Q2 2020 | $77,000 | -95.9% | 481 | -97.5% | 0.00% | -100.0% |
| Q1 2020 | $1,864,000 | -25.8% | 19,063 | -2.1% | 0.00% | 0.0% |
| Q4 2019 | $2,513,000 | +9.2% | 19,476 | -36.2% | 0.00% | 0.0% |
| Q3 2019 | $2,302,000 | -62.7% | 30,548 | -24.7% | 0.00% | -66.7% |
| Q2 2019 | $6,167,000 | -23.0% | 40,584 | -39.6% | 0.01% | -25.0% |
| Q1 2019 | $8,011,000 | -9.0% | 67,215 | -16.7% | 0.01% | -20.0% |
| Q4 2018 | $8,804,000 | -48.1% | 80,673 | -23.2% | 0.01% | -37.5% |
| Q3 2018 | $16,956,000 | +16.9% | 104,989 | -4.3% | 0.02% | +14.3% |
| Q2 2018 | $14,503,000 | +67.3% | 109,728 | -6.2% | 0.01% | +55.6% |
| Q1 2018 | $8,668,000 | +16.0% | 116,988 | -12.9% | 0.01% | +28.6% |
| Q4 2017 | $7,473,000 | +1.1% | 134,314 | -17.6% | 0.01% | -12.5% |
| Q3 2017 | $7,389,000 | +1095.6% | 162,921 | +787.4% | 0.01% | +700.0% |
| Q2 2017 | $618,000 | +347.8% | 18,360 | +293.5% | 0.00% | – |
| Q1 2017 | $138,000 | +170.6% | 4,666 | +150.1% | 0.00% | – |
| Q4 2016 | $51,000 | -61.4% | 1,866 | -13.9% | 0.00% | – |
| Q3 2016 | $132,000 | +7.3% | 2,166 | -66.3% | 0.00% | – |
| Q2 2016 | $123,000 | -25.0% | 6,423 | -23.8% | 0.00% | – |
| Q1 2016 | $164,000 | -62.6% | 8,426 | -25.5% | 0.00% | -100.0% |
| Q4 2015 | $438,000 | +69.8% | 11,317 | +41.2% | 0.00% | – |
| Q3 2015 | $258,000 | +0.8% | 8,017 | -4.7% | 0.00% | – |
| Q2 2015 | $256,000 | +130.6% | 8,409 | +1.2% | 0.00% | – |
| Q1 2015 | $111,000 | +2.8% | 8,310 | +10.7% | 0.00% | – |
| Q4 2014 | $108,000 | -39.3% | 7,510 | -11.2% | 0.00% | – |
| Q3 2014 | $178,000 | -23.3% | 8,453 | +8.4% | 0.00% | – |
| Q2 2014 | $232,000 | +26.1% | 7,800 | +2.6% | 0.00% | – |
| Q1 2014 | $184,000 | +26.0% | 7,600 | +5.6% | 0.00% | – |
| Q4 2013 | $146,000 | -72.4% | 7,200 | -35.7% | 0.00% | -100.0% |
| Q3 2013 | $529,000 | +24.2% | 11,200 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $426,000 | – | 11,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |